Ep 14 | All About 340B Grantees (Part 2)
340B Unscripted6 Mar 2023

Ep 14 | All About 340B Grantees (Part 2)

This is part two of our two-part series focusing on 340B grantee-covered entities. The team talks about the importance of maintaining auditable records (15:34) and the challenges that many grantees face in meeting this 340B eligibility requirement. Also, they cover important billing considerations related to Medicaid Duplicate Discount prevention (31:20). Finally, the group debates future developments that 340B grantee-covered entities should keep on their radar through 2023 (45:52).

But first, Greg and Rob catch up on 340B implications from the Consolidated Appropriations Act of 2023 and share insights from a recent publication (J Manag Care Spec Pharm. 2023;29(3):229-35) that predicts which drugs will be subject to Medicare price negotiations starting in 2026 and beyond.

Episoder(91)

Ep 23 | 340B and the Medicare Cost Report

Ep 23 | 340B and the Medicare Cost Report

Greg and Rob break down the ins and outs of the Medicare Cost Report and the dos and don'ts of child site registrations. They also provide an update on contract pharmacy manufacturer restrictions and ...

3 Jul 202357min

Ep 22 | Maintaining 340B Compliance: Medicaid Duplicate Discount Prevention

Ep 22 | Maintaining 340B Compliance: Medicaid Duplicate Discount Prevention

In this episode, Greg and Rob talk about an important 340B Program compliance element – preventing Medicaid duplicate discounts.  They discuss the importance of maintaining the Medicaid Exclusion File...

19 Jun 20231h 4min

Ep 21 | Thoughts on 340B & Biosimilar Uptake

Ep 21 | Thoughts on 340B & Biosimilar Uptake

In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization.  Additionally, the guys recap recent legislative pr...

5 Jun 202340min

Ep 20 | 340B History Lesson – The Morford Letter

Ep 20 | 340B History Lesson – The Morford Letter

In this episode, Rob and Greg discuss an interesting piece of 340B history – the Morford letter (25:31).  Rob shares his understanding of the origins of the letter and contemporary application of the ...

22 Mai 202354min

Bonus Ep 1 | New 340B Location Qualification and FAQ 4301 Update

Bonus Ep 1 | New 340B Location Qualification and FAQ 4301 Update

Greg and Rob provide a quick update on FAQ 4301 and where we are with HRSA removing language around the immediate use of new 340B locations.

15 Mai 202316min

Ep 19 (Update) | HRSA FAQ 4301 Developments

Ep 19 (Update) | HRSA FAQ 4301 Developments

8 Mai 20233min

Ep 19 | 340B D.C. Update – Conversation with Ted Slafsky

Ep 19 | 340B D.C. Update – Conversation with Ted Slafsky

In this episode, Rob and Greg are joined by guest Ted Slafsky, of 340B Report and Wexford Solutions (13:20). Ted shares his thoughts on the ongoing contract pharmacy impasse, updates on legislative de...

8 Mai 20231h 9min

Ep 18 | 340B Program Reform – A Conversation with NACHC

Ep 18 | 340B Program Reform – A Conversation with NACHC

This week, Rob and Greg connected with Vacheria Keys, Director of Policy & Regulatory Affairs at NACHC. Vacheria will talk about her role at NACHC and how the health centers she represents have been i...

24 Apr 20231h 11min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
lydartikler-fra-aftenposten
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
pengepodden-2
finansredaksjonen
utbytte
pengesnakk
livet-pa-veien-med-jan-erik-larssen
tid-er-penger-en-podcast-med-peter-warren
stormkast-med-valebrokk-stordalen
rss-sunn-okonomi
morgenkaffen-med-finansavisen
okonomiamatorene
lederpodden
rss-markedspuls-2
flypodden
rss-trygg-av-natur